Hotei Hospital

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Schizophrenia2 trials

Phase

• Phase 32 trials

Status

• Active, not recruiting1 trial
• Terminated1 trial

Lead sponsor

• Otsuka Pharmaceutical Development & Commercialization, Inc.1 trial
• Sumitomo Pharma Co., Ltd.1 trial

Running trials

• Active, not recruiting

  A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia

  NCT06894212· Phase 3· Otsuka Pharmaceutical Development & Commercialization, Inc.· Source

Closed trials

• Terminated

  A Clinical Trial to Evaluate the Long-term Safety and Tolerability of SEP-363856 in Patients With Schizophrenia in Japan

  NCT05359081· Phase 3· Sumitomo Pharma Co., Ltd.· Source